[Question] Australia — has anyone got a straight answer on hepatic fat
Genuinely asking, not being difficult. Everyone in c/tirzepatide repeats that biopsy is important. I believe it, but I have never seen anyone show why, and when I search I get 8 threads of people agreeing with each other. Is there a paper? Is there a measurement? Or is this one of those things that is true because it…
Yeah, glucagon co-agonism is genuinely different.
rodent survodutide is investigation only
glucagon injection is a different vector than GLP-1
My version of this: I was so worried about the injection that I put it off for eleven days. The injection is the easiest part.
Yeah, glucagon co-agonism is genuinely different.
The thing nobody prepared me for was the quiet. Not the appetite, the quiet. The constant negotiation in my head about food just stopped.
The thing nobody prepared me for was the quiet.
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
the safety profile is not just tirzepatide amplified
The thing nobody prepared me for was the quiet.
Adding to this: biopsy is doing more work than the comment implies.
Week 22 for me and the honest summary is: 11kg down, muscle cramps manageable, and I have thought about food maybe four times today.